Lanean...
An overview of prevalence, determinants and health outcomes of polypharmacy
A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are likely to be on a polypharmacy regime, is lim...
Gorde:
| Argitaratua izan da: | Ther Adv Drug Saf |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294476/ https://ncbi.nlm.nih.gov/pubmed/32587680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098620933741 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|